Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Idorsia Pharmaceuticals Ltd ×

Idorsia Pharmaceuticals Ltd

This funder is selected. Its supporting articles are shown below.

Idorsia Pharmaceuticals Ltd2

Articles mentioning Idorsia Pharmaceuticals Ltd

2 articles · page 1 of 1

P3 Effect of daridorexant on patients with comorbid insomnia disorder and untreated mild obstructive sleep apnea: a post-hoc analysis of a phase 3 study

bmjresp · abstract · 2026-05-07 · 1 matching annotations

83.0%

Idorsia Pharmaceuticals Ltd Visual Analogue Scale daridorexant obstructive sleep apnea NCT03545191 insomnia disorder OSA

…h an acceptable safety profile.Funding This study was funded by Idorsia Pharmaceuticals Ltd…

P6 Repeated dosing of 50 mg daridorexant in patients with severe obstructive sleep apnea: Effect on sleep-disordered breathing and sleep

bmjresp · abstract · 2026-05-07 · 1 matching annotations

84.1%

Idorsia Pharmaceuticals Ltd Daridorexant chronic insomnia disorder OSA

…sleep-disordered breathing, independent of OSA severity.Funding Idorsia Pharmaceuticals Ltd…